Last week, TBC’ers volunteered at @communityserv, a Boston-based nonprofit that prepares nutritious meals for individuals and families facing critical and chronic illnesses. Giving back to our community is core to our mission at Ten Bridge, and partnering with Community Servings is always an inspiring experience. We were proud to support their commitment to providing nutritious, home-delivered meals to those in need. We’re already looking forward to our next visit!

We were thrilled to be joined by @endpts co-founder @arsalanarif at our team offsite this week. Thank you, Arsalan, for sharing your valuable insights and perspectives with us on the growth of Endpoints and what's to come in the industry.

Last week, some members of our team volunteered with the @CharlesRiver Watershed Association to remove invasive water chestnuts from the Charles River here in Massachusetts. Water chestnuts are an invasive aquatic plant found in the Charles River. They are rosette shaped and fast growing, thus blocking out other life in the river. Thanks to the CRWAs efforts, they have removed over 100 tons of water chestnuts from the Charles. Our team helped remove another 106 baskets of water chestnuts. Well done team, and thank you to the CRWA for another amazing volunteer experience!

Earlier this year, we had the privilege of partnering with #TBCPartner Clasp Therapeutics to launch their company and announce their Series A. Clasp is developing off-the-shelf precision immuno-oncology therapeutics to target hard-to-treat tumors with absolute specificity. Their launch was incredibly impactful, receiving some great recognition across key media outlets. Some of the communications highlights included: - 19 feature stories - 37 total pieces of coverage - Gained 2,500 LinkedIn followers in the first 24 hours following launch Learn more about our collaboration with Clasp in our recent case study: tenbridgecommunications.com/…

Last week, we volunteered at @communityserv, one of our favorite organizations in the Boston area. Community Servings prepares medically tailored meals for people in Massachusetts who are living with chronic illnesses. Giving back to our local community is something we truly value and could not think of a better partner with which to do so. We’re looking forward to our next visit.

We have the privilege of partnering with clients on the leading edge of science, from leaders in gene editing to tRNA therapeutics, chemoproteomics and beyond. As a core strategic partner to those setting the pace in biotech, we help build bridges that can speed the translation of new discoveries into the next new modalities for patients. Hear from some of our team members about the work we do to propel the success of biotech’s pioneers.

Did you know that @hootsuite recommends videos of 30 and 44 seconds for LinkedIn and X, respectively? On the one hand, it can be difficult to boil down all you want to say in to such a short amount of time. On the other, users’ attention on these channels is precious and fleeting. We covered how to leverage short form video in our recent article, “So you made a video...” – give it a read: bit.ly/4awybqV

Last week, nearly the entire Ten Bridge team gathered in our Boston headquarters for a week of collaborating in-person. We also took it as an opportunity to get together outside the office for some rock climbing and bowling. We love getting to have these moments to connect as a group and so appreciate all our remote team members who made the trip to Boston.

What do digital strategies and clinical trial design have in common? They both leverage data to measure success. Traditionally, digital marketing focuses on generating revenue. But with an early-stage biotech, you may be many years away from having an approved product. So how do you measure the success of your digital strategy? You set some primary endpoints. In our most recent article, Matthew Zola lays out a process for designing a digital strategy and measuring success for business goals across the biotech spectrum. Give it a read on “The biotech world in perspective.” bit.ly/4c9jxY1

Drug development is a slow process. Particularly for those brave enough to create a new modality or platform, it can take quite a while to advance a program into the clinic. So if you recently launched, how do you keep investors, job seekers and the biotech community at large apprised of your progress? Get on social. @ChrisJRailey recently covered how important social can be for the recently launched biotech. Give his article a read over on “The Biotech World in Perspective.” bit.ly/47QDv6L